Being born small for gestational age was linked to a lower risk of adult-onset MS. Exposure to maternal diabetes during ...
On February 25, 2026, a Washington, D.C. federal court allowed a religious discrimination lawsuit against the U.S. Department ...
Both non-transfusion-dependent and transfusion dependent cohorts met their respective primary and secondary endpointsPRINCETON, N.J.--(BUSINESS WIRE)--$BMY #BMS--Bristol Myers Squibb (NYSE: BMY) today ...
Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) ―― 20 mg ...
Announced positive 12-week results from the 20 mg dose cohort of the Phase 1b PIONEER trial of pociredir in sickle cell disease (SCD) - 20 mg cohort demonstrated rapid and robust fetal hemoglobin (HbF ...
CNS(Vafidemstat) Appointed renowned Rolando Gutierrez-Esteinou, M.D. as new CMO for CNSPreparing protocol resubmission to incorporate ...
Lawmaker has introduced a bill requiring Utah schools to show students videos of fertilization and development of a fetus ...
Six pregnant women participated in a small trial in which placenta-derived stem cells were applied to fetal spinal cords and the treatment was found to be safe.
The Defense Department used a high-energy laser to shoot down a drone belonging to the Department of Homeland Security over a small border town near El Paso Thursday, prompting the Federal Aviation ...
Jury Returns Verdict Following Four-Week Trial Involving 2017 Labor and Delivery While nothing can undo Dylan’s injury, ...
General and administrative expenses were $1.7 and $5.6 million for the quarter and twelve months ended December 31, 2025, ...
Bristol Myers Squibb today announced positive top-line results from the ongoing, ex-US, Phase 2 registrational study (NCT05664737) evaluating Reblozyl® (luspatercept-aamt) versus placebo for anemia in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results